ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/06 | 2,129 | 2,129 | 2,071 | 2,073 | -56 | -2.6% | 101,200 |
2017/12/05 | 2,115 | 2,132 | 2,101 | 2,129 | +5 | +0.2% | 54,600 |
2017/12/04 | 2,165 | 2,166 | 2,123 | 2,124 | -21 | -1% | 58,300 |
2017/12/01 | 2,176 | 2,176 | 2,141 | 2,145 | -25 | -1.2% | 68,800 |
2017/11/30 | 2,140 | 2,177 | 2,131 | 2,170 | +18 | +0.8% | 91,600 |
2017/11/29 | 2,130 | 2,153 | 2,121 | 2,152 | +34 | +1.6% | 63,800 |
2017/11/28 | 2,120 | 2,131 | 2,111 | 2,118 | +14 | +0.7% | 52,200 |
2017/11/27 | 2,102 | 2,121 | 2,100 | 2,104 | +2 | +0.1% | 59,600 |
2017/11/24 | 2,115 | 2,115 | 2,094 | 2,102 | -19 | -0.9% | 59,500 |
2017/11/22 | 2,150 | 2,152 | 2,121 | 2,121 | -16 | -0.7% | 52,300 |
2017/11/21 | 2,131 | 2,154 | 2,131 | 2,137 | -10 | -0.5% | 43,400 |
2017/11/20 | 2,134 | 2,151 | 2,114 | 2,147 | +24 | +1.1% | 63,900 |
2017/11/17 | 2,150 | 2,155 | 2,117 | 2,123 | -10 | -0.5% | 59,100 |
2017/11/16 | 2,104 | 2,142 | 2,083 | 2,133 | +29 | +1.4% | 111,200 |
2017/11/15 | 2,135 | 2,144 | 2,103 | 2,104 | -67 | -3.1% | 102,200 |
2017/11/14 | 2,155 | 2,190 | 2,154 | 2,171 | +27 | +1.3% | 121,300 |
2017/11/13 | 2,131 | 2,154 | 2,131 | 2,144 | -14 | -0.6% | 76,300 |
2017/11/10 | 2,116 | 2,161 | 2,116 | 2,158 | +42 | +2% | 180,600 |
2017/11/09 | 2,125 | 2,148 | 2,102 | 2,116 | -4 | -0.2% | 168,700 |
2017/11/08 | 2,132 | 2,145 | 2,110 | 2,120 | -39 | -1.8% | 94,400 |
2017/11/07 | 2,184 | 2,184 | 2,130 | 2,159 | -36 | -1.6% | 201,700 |
2017/11/06 | 2,020 | 2,197 | 2,015 | 2,195 | +223 | +11.3% | 716,100 |
2017/11/02 | 1,972 | 1,977 | 1,957 | 1,972 | -7 | -0.4% | 93,900 |
2017/11/01 | 1,978 | 1,983 | 1,965 | 1,979 | -5 | -0.3% | 145,500 |
2017/10/31 | 2,002 | 2,002 | 1,977 | 1,984 | -22 | -1.1% | 96,000 |
2017/10/30 | 2,015 | 2,022 | 2,000 | 2,006 | -31 | -1.5% | 122,400 |
2017/10/27 | 2,014 | 2,040 | 2,010 | 2,037 | +38 | +1.9% | 162,000 |
2017/10/26 | 2,007 | 2,007 | 1,996 | 1,999 | -14 | -0.7% | 81,900 |
2017/10/25 | 2,019 | 2,021 | 2,009 | 2,013 | -6 | -0.3% | 110,300 |
2017/10/24 | 2,020 | 2,022 | 2,006 | 2,019 | -4 | -0.2% | 101,000 |
2017/10/23 | 1,969 | 2,034 | 1,969 | 2,023 | +64 | +3.3% | 241,200 |
2017/10/20 | 1,971 | 1,976 | 1,952 | 1,959 | -13 | -0.7% | 124,400 |
2017/10/19 | 1,989 | 1,989 | 1,972 | 1,972 | -10 | -0.5% | 94,100 |
2017/10/18 | 1,979 | 1,989 | 1,975 | 1,982 | +2 | +0.1% | 71,000 |
2017/10/17 | 2,016 | 2,016 | 1,978 | 1,980 | -35 | -1.7% | 157,700 |
2017/10/16 | 2,010 | 2,022 | 2,007 | 2,015 | ±0 | ±0% | 83,800 |
2017/10/13 | 2,010 | 2,018 | 2,004 | 2,015 | -2 | -0.1% | 133,300 |
2017/10/12 | 2,014 | 2,022 | 2,007 | 2,017 | +6 | +0.3% | 85,700 |
2017/10/11 | 2,008 | 2,015 | 2,003 | 2,011 | -2 | -0.1% | 99,300 |
2017/10/10 | 2,008 | 2,017 | 2,005 | 2,013 | +5 | +0.2% | 58,200 |
2017/10/06 | 2,010 | 2,013 | 2,003 | 2,008 | +2 | +0.1% | 82,500 |
2017/10/05 | 2,007 | 2,013 | 2,003 | 2,006 | ±0 | ±0% | 97,200 |
2017/10/04 | 2,022 | 2,022 | 2,003 | 2,006 | -12 | -0.6% | 84,500 |
2017/10/03 | 2,028 | 2,034 | 2,003 | 2,018 | -19 | -0.9% | 127,000 |
2017/10/02 | 2,018 | 2,043 | 2,018 | 2,037 | +26 | +1.3% | 181,600 |
2017/09/29 | 2,000 | 2,012 | 1,998 | 2,011 | ±0 | ±0% | 153,600 |
2017/09/28 | 2,020 | 2,020 | 2,003 | 2,011 | -7 | -0.3% | 102,900 |
2017/09/27 | 2,011 | 2,019 | 2,001 | 2,018 | -11 | -0.5% | 116,000 |
2017/09/26 | 2,027 | 2,044 | 2,023 | 2,029 | +3 | +0.1% | 224,100 |
2017/09/25 | 2,015 | 2,027 | 2,006 | 2,026 | +17 | +0.8% | 170,100 |
1701~
1750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,700円 | +13.6% | +29.2% | 2.04% | 11.71倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 475,500円 | +12.0% | +28.1% | 2.52% | 26.21倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,400円 | +197.7% | - | 0.00% | 46.34倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,700円 | +3.2% | +4.5% | 3.47% | 17.20倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム